Cambridge Investment Research Advisors, Inc. United Therapeutics Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 6,968 shares of UTHR stock, worth $2.15 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,968
Previous 11,176
37.65%
Holding current value
$2.15 Million
Previous $4.01 Million
38.6%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding UTHR
# of Institutions
725Shares Held
40.4MCall Options Held
123KPut Options Held
104K-
Black Rock Inc. New York, NY5.47MShares$1.69 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.37 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$851 Million14.19% of portfolio
-
State Street Corp Boston, MA2.2MShares$678 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.09MShares$644 Million1.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...